ESSA Pharma Inc (EPIX)
NASDAQ:EPIX
US Market
Holding EPIX?
Track your performance easily

ESSA Pharma (EPIX) Financial Statements

269 Followers

ESSA Pharma Financial Overview

ESSA Pharma's market cap is currently ―. The company's EPS TTM is $-0.625; its P/E ratio is -2.83; ESSA Pharma is scheduled to report earnings on December 10, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -7.23M$ -8.99M$ -5.96M$ -5.48M$ -7.30M
EBITDA$ -6.79M$ -8.97M$ -5.94M$ -5.64M$ -6.99M
Net Income Common Stockholders$ -7.23M$ -8.99M$ -5.96M$ -5.48M$ -7.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 130.69M$ 135.89M$ 142.12M$ 148.08M$ 152.47M
Total Assets$ 132.67M$ 137.90M$ 144.49M$ 149.12M$ 153.65M
Total Debt$ 342.14K$ 353.66K$ 374.83K$ 80.33K$ 111.27K
Net Debt$ -130.35M$ -135.54M$ -141.74M$ -148.00M$ -152.36M
Total Liabilities$ 3.80M$ 4.43M$ 3.81M$ 3.50M$ 3.41M
Stockholders Equity$ 128.86M$ 133.47M$ 140.68M$ 145.63M$ 150.24M
Cash Flow-
Free Cash Flow$ -5.75M$ -6.82M$ -6.79M$ -4.49M$ -4.91M
Operating Cash Flow$ -5.75M$ -6.82M$ -6.79M$ -4.49M$ -4.91M
Investing Cash Flow$ 23.49K$ 62.51M$ 8.23M$ -264.65K$ -891.15K
Financing Cash Flow$ 25.58K$ 643.60K$ 196.66K$ -13.65K$ -35.52K
Currency in USD

ESSA Pharma Earnings and Revenue History

ESSA Pharma Debt to Assets

ESSA Pharma Cash Flow

ESSA Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis